March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A SubmicroVolt Focal ERG Technique for Evaluating Macular Function in Stargardt/FF Dystrophy: Clinical Assessment of Test Reliability
Author Affiliations & Notes
  • Benedetto Falsini
    Ophthalmology, Catholic University, Rome, Italy
  • Marco Piccardi
    Ophthalmology, Catholic University, Rome, Italy
  • Dario Marangoni
    Ophthalmology, Catholic University, Rome, Italy
  • Angelo Minnella
    Ophthalmology, Catholic University, Rome, Italy
  • Matteo Bertelli
    Ophthalmology, MAGI Laboratory for molecular genetics in rare diseases, Rovereto, Trento, Italy
  • Silvia Bisti
    Physiology, University of L'Aquila, L'Aquila, Italy
  • Antonello Fadda
    Health and Technology, Istituto Superiore di Sanita, Rome, Italy
  • Footnotes
    Commercial Relationships  Benedetto Falsini, None; Marco Piccardi, None; Dario Marangoni, None; Angelo Minnella, None; Matteo Bertelli, None; Silvia Bisti, None; Antonello Fadda, None
  • Footnotes
    Support  Telethon Grant GGP10149 to BF
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6434. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benedetto Falsini, Marco Piccardi, Dario Marangoni, Angelo Minnella, Matteo Bertelli, Silvia Bisti, Antonello Fadda; A SubmicroVolt Focal ERG Technique for Evaluating Macular Function in Stargardt/FF Dystrophy: Clinical Assessment of Test Reliability. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6434.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the reliability in a clinical setting of a submicroVolt focal ERG (fERG) technique for evaluating macular function in Stargardt/FF (STDG/FF) dystrophy patients

Methods: : Twenty-six ABCA4- genotyped STDG/FF patients (14/12 M/F, age: 9-32 years; Snellen acuity 0.3-0.8, stable central fixation) and 26 age-matched control subjects were included in the study. fERGs were recorded from the macular region (18 deg) in response to a 41 Hz sinusoidally flickering uniform field on a light adapting background. Sixteen block averages (of 200 events each) were obtained for each eye and recording session (2 to 4 in separate occasions). fERG fundamental component was analyzed for each block to derive amplitude, phase and vector standard error (SE). Noise at the fundamental was estimated on signals averaged asynchronously at 1.1 times stimulus temporal frequency. Intra-test reliability was determined by taking into account either S/N ratio or vector SE

Results: : Although average fERG reliability was lower (p < 0.01) in STDG/FF patients compared to controls, most patients’ responses differed significantly (p < 0.05) from noise. Lowest cut-off reliability, corresponding to a S/N ratio=3, was found in 2 out of 26 patients (7.7%). Test-retest amplitude variability was 0.12 logmicroV in both STGD/FF patients and controls

Conclusions: : The present fERG protocol in STDG/FF provided a reliable macular function test with potential application for monitoring disease progression and treatment

Keywords: retinal degenerations: hereditary • electroretinography: clinical • clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×